DE60140120D1 - Toxizitätstypisierung unter verwendung von leberstammzellen - Google Patents

Toxizitätstypisierung unter verwendung von leberstammzellen

Info

Publication number
DE60140120D1
DE60140120D1 DE60140120T DE60140120T DE60140120D1 DE 60140120 D1 DE60140120 D1 DE 60140120D1 DE 60140120 T DE60140120 T DE 60140120T DE 60140120 T DE60140120 T DE 60140120T DE 60140120 D1 DE60140120 D1 DE 60140120D1
Authority
DE
Germany
Prior art keywords
toxicity
chemical compositions
typing
toxicities
molecular profiles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140120T
Other languages
English (en)
Inventor
H Ralph Snodgrass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vistagen Inc
Original Assignee
Vistagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistagen Inc filed Critical Vistagen Inc
Application granted granted Critical
Publication of DE60140120D1 publication Critical patent/DE60140120D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
DE60140120T 2000-06-14 2001-06-14 Toxizitätstypisierung unter verwendung von leberstammzellen Expired - Lifetime DE60140120D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21160600P 2000-06-14 2000-06-14
PCT/US2001/019187 WO2001096866A1 (en) 2000-06-14 2001-06-14 Toxicity typing using liver stem cells

Publications (1)

Publication Number Publication Date
DE60140120D1 true DE60140120D1 (de) 2009-11-19

Family

ID=22787620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140120T Expired - Lifetime DE60140120D1 (de) 2000-06-14 2001-06-14 Toxizitätstypisierung unter verwendung von leberstammzellen

Country Status (12)

Country Link
US (3) US20020012905A1 (de)
EP (1) EP1290444B1 (de)
JP (1) JP2004503256A (de)
KR (1) KR100865664B1 (de)
AT (1) ATE445158T1 (de)
AU (1) AU2001268449A1 (de)
CA (1) CA2412361C (de)
DE (1) DE60140120D1 (de)
DK (1) DK1290444T3 (de)
ES (1) ES2334639T3 (de)
HK (1) HK1054980A1 (de)
WO (1) WO2001096866A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7555492B2 (en) * 1999-11-05 2009-06-30 The Board Of Trustees At The Leland Stanford Junior University System and method for internet-accessible tools and knowledge base for protocol design, metadata capture and laboratory experiment management
WO2001096866A1 (en) 2000-06-14 2001-12-20 Vistagen, Inc. Toxicity typing using liver stem cells
US20050060102A1 (en) * 2000-10-12 2005-03-17 O'reilly David J. Interactive correlation of compound information and genomic information
CA2471661A1 (en) * 2002-01-31 2003-08-07 Gene Logic, Inc. Molecular hepatotoxicology modeling
EP1578393A4 (de) * 2002-02-04 2008-03-19 Gene Logic Inc Primäre ratten-hepatozyten-toxizitätsmodellierung
US20040067507A1 (en) * 2002-05-10 2004-04-08 Nolan Timothy D. Liver inflammation predictive genes
WO2004097585A2 (en) * 2003-04-24 2004-11-11 Stanford University System and method for internet-accessible tools and knowledge base for protocol design, metadata capture and laboratory experiment management
CA2533922A1 (en) * 2003-08-07 2005-02-17 Gene Logic, Inc. Primary rat hepatocyte toxicity modeling
EP1697873A4 (de) * 2003-11-24 2008-01-23 Gene Logic Inc Verfahren zur modellierung molekularer toxikologie
CN1914313A (zh) * 2004-02-13 2007-02-14 旭科技玻璃股份有限公司 胚胎干细胞用喂食细胞培育培养基及喂食细胞
WO2005124650A2 (en) * 2004-06-10 2005-12-29 Iconix Pharmaceuticals, Inc. Sufficient and necessary reagent sets for chemogenomic analysis
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20060040338A1 (en) * 2004-08-18 2006-02-23 Odyssey Thera, Inc. Pharmacological profiling of drugs with cell-based assays
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
WO2006077981A1 (ja) * 2005-01-21 2006-07-27 Miyazaki Prefecture 高スループット機能性評価方法、プログラム、及び装置
JP4721752B2 (ja) * 2005-04-06 2011-07-13 独立行政法人科学技術振興機構 妊娠状態における薬物代謝予測法
US7795390B2 (en) 2005-06-24 2010-09-14 Teijin Pharma Limited Biological substance nesfatin and its related substances and uses thereof
KR20120005558A (ko) 2005-09-20 2012-01-16 마이크로 모우션, 인코포레이티드 진동 유량계에 대한 구동 신호를 생성하기 위한 방법 및 계측 전자장치
US20070198653A1 (en) * 2005-12-30 2007-08-23 Kurt Jarnagin Systems and methods for remote computer-based analysis of user-provided chemogenomic data
DK1966367T3 (da) * 2005-12-30 2010-05-03 Drugmode Aps Bioreaktor til celle- og vævskultur
US20100021885A1 (en) * 2006-09-18 2010-01-28 Mark Fielden Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity
GB2457832A (en) * 2006-10-02 2009-09-02 Cellartis Ab Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
EP2342359B1 (de) * 2008-08-01 2015-03-04 Brown University System und verfahren zur bestimmung von molekülen anhand von massenspektrometrie sowie entsprechende verfahren
GB201103828D0 (en) * 2011-03-07 2011-04-20 Dundee Cell Products Ltd Evaluation of therapeutic agent
JP5820320B2 (ja) * 2012-03-27 2015-11-24 株式会社東芝 情報処理端末及び方法、並びに、情報管理装置及び方法
US20170273611A1 (en) * 2014-08-22 2017-09-28 The General Hospital Corporation Systems and methods for discovery and characterization of neuroactive drugs
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
US10303757B2 (en) 2016-08-19 2019-05-28 Cognex Corporation Apparatuses, systems, and methods for providing a visual program for machine vision systems
KR102083408B1 (ko) * 2017-04-28 2020-03-02 가천대학교 산학협력단 줄기세포 기반의 독성 물질 스크리닝 방법
CN111549112A (zh) * 2020-04-02 2020-08-18 中国农业大学 一种丙烯酰胺暴露检测的标志物及其应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS191501B1 (en) 1976-04-02 1979-07-31 Richard Jelinek Method of testing the embryotoxicity on the chicken embryo
US4973493A (en) 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US5328695A (en) 1983-03-22 1994-07-12 Massachusetts Institute Of Technology Muscle morphogenic protein and use thereof
US5200313A (en) 1983-08-05 1993-04-06 Miles Inc. Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
US4569774A (en) 1984-11-13 1986-02-11 Mobil Oil Corporation Polyglycol lubricants comprising trifluoromethane sulfonate
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
PT87133B (pt) 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5506131A (en) 1987-06-05 1996-04-09 The United States Of America As Represented By The Department Of Health And Human Services Immortalized human cell lines containing exogenous cytochrome P450 genes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5002867A (en) 1988-04-25 1991-03-26 Macevicz Stephen C Nucleic acid sequence determination by multiple mixed oligonucleotide probes
AU623922B2 (en) 1988-08-04 1992-05-28 Amrad Operations Pty. Limited In vitro propagation of embryonic stem cells
SE463386B (sv) 1989-03-17 1990-11-12 Nilas Tore Nilsson Anordning foer bildvisning
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
EP0553258A4 (en) 1990-10-17 1993-09-22 Jack D. Love Identification and paternity determination by detecting presence or absence of multiple nucleic acid sequences
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
EP0562047A4 (en) 1990-12-06 1995-11-02 Affymax Tech Nv Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
JPH06319535A (ja) 1991-04-12 1994-11-22 Bio Material Kenkyusho:Kk 株化肝細胞
WO1993003142A1 (en) 1991-08-07 1993-02-18 Albert Einstein College Of Medicine Proliferation of hepatocyte precursors
US6069005A (en) 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
DE69333650T2 (de) 1992-02-19 2006-01-12 The Public Health Research Institute Of The City Of New York, Inc. Neue anordnungn von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzieren und manipulieren von nukleinsäuren
AU4387193A (en) 1992-05-29 1993-12-30 Abbott Laboratories Ligase chain reaction starting with rna sequences
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
DK0671923T3 (da) 1992-10-09 2001-08-13 Advanced Tissue Sciences Inc Leverreserveceller
AU692434B2 (en) 1993-01-21 1998-06-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
US6027880A (en) 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
US5459037A (en) 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5773213A (en) 1994-06-06 1998-06-30 Brigham & Women's Hospital Method for conducting sequential nucleic acid hybridization steps
RU2111254C1 (ru) 1994-07-11 1998-05-20 Институт молекулярной биологии им.В.А.Энгельгардта РАН СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5861313A (en) 1995-06-07 1999-01-19 Ontogeny, Inc. Method of isolating bile duct progenitor cells
US5705365A (en) 1995-06-07 1998-01-06 Gen-Probe Incorporated Kits for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product
DE19525285C2 (de) 1995-06-28 1999-04-15 Inst Pflanzengenetik & Kultur In vitro Testverfahren zum Nachweis Chemikalien-induzierter embryotoxischer/teratogener Effekte
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5972693A (en) 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5736332A (en) 1995-11-30 1998-04-07 Mandecki; Wlodek Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
AU735440B2 (en) 1996-02-09 2001-07-05 Cornell Research Foundation Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
DE19606207A1 (de) 1996-02-21 1997-08-28 Univ Duesseldorf H Heine Verfahren zur Bestimmung der Phototoxizität und/oder Photosensibilität von Stoffen oder Stoffgemischen sowie dessen Verwendung
US5811297A (en) 1996-03-07 1998-09-22 Amba Biosciences, Llc Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
WO1997046313A1 (en) 1996-06-07 1997-12-11 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
AU3392697A (en) 1996-06-14 1998-01-07 Regents Of The University Of California, The (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof
US5800690A (en) 1996-07-03 1998-09-01 Caliper Technologies Corporation Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
CN1230989A (zh) 1996-08-19 1999-10-06 马萨诸塞大学 通过种间核移植制备胚胎细胞或干细胞样细胞系
AU4495497A (en) 1996-09-19 1998-04-14 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
JPH10179150A (ja) 1996-10-22 1998-07-07 Sumitomo Bakelite Co Ltd 肝細胞培養方法及び薬物代謝能測定方法
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
AU9200298A (en) 1997-08-22 1999-03-16 Yale University A process to study changes in gene expression in stem cells
WO1999023254A1 (en) * 1997-10-31 1999-05-14 Affymetrix, Inc. Expression profiles in adult and fetal organs
CA2310621A1 (en) * 1997-11-20 1999-06-03 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
JP4383533B2 (ja) 1998-02-23 2009-12-16 フィロニクス ファーマシューティカルズ， インコーポレイテッド 真骨魚類を使用する、活性についての薬剤のスクリーニング方法
AU756731C (en) * 1998-02-25 2004-07-29 Canton Of Basel-Stadt Cellular arrays for rapid molecular profiling
US20020142976A1 (en) * 1998-04-27 2002-10-03 Icos Corporation Materials and methods for modulating differentiation
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000018960A2 (en) * 1998-09-25 2000-04-06 Massachusetts Institute Of Technology Methods and products related to genotyping and dna analysis
EP1128836A2 (de) 1998-11-13 2001-09-05 Osiris Therapeutics, Inc. Transplantation von menschlichen mesenchymalen stamzellen in der gebärmutter
KR20010080722A (ko) 1998-12-09 2001-08-22 추후제출 배형체를 사용한 독성 타이핑
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
EP1257282A4 (de) * 1999-12-06 2003-05-02 Gen Hospital Corp Pankreatische stammzellen und deren verwendung in transplantation
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
JP2004503255A (ja) 2000-06-14 2004-02-05 ビスタジェン　インコーポレイテッド 間葉幹細胞を使用する毒性の分類
WO2001096866A1 (en) 2000-06-14 2001-12-20 Vistagen, Inc. Toxicity typing using liver stem cells
US20070111257A1 (en) * 2005-07-07 2007-05-17 Kohne David E Improved protein expression comparison assay results and applications

Also Published As

Publication number Publication date
EP1290444A1 (de) 2003-03-12
AU2001268449A1 (en) 2001-12-24
US20020012905A1 (en) 2002-01-31
EP1290444B1 (de) 2009-10-07
ES2334639T3 (es) 2010-03-15
ATE445158T1 (de) 2009-10-15
CA2412361C (en) 2011-08-23
US8143009B2 (en) 2012-03-27
DK1290444T3 (da) 2010-01-18
US8512957B2 (en) 2013-08-20
US20120220469A1 (en) 2012-08-30
KR100865664B1 (ko) 2008-10-29
KR20030009532A (ko) 2003-01-29
JP2004503256A (ja) 2004-02-05
US20070111195A1 (en) 2007-05-17
WO2001096866A1 (en) 2001-12-20
HK1054980A1 (zh) 2003-12-19
CA2412361A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
DE60140120D1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
AU6152301A (en) Detection of nucleic acid hybridization by fluorescence polarization
ID26328A (id) Penghambat raf kinase menggunakan urea heterosiklik tersubstitusi aril dan heteroaril
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
HK1152378A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
DE69735445D1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
ATE512233T1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
ATE330038T1 (de) Nukleinsäure-biosensor
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DE60328001D1 (de) Elektrochemische nachweissystemen
EA200300880A1 (ru) Способ детекции нуклеотидного полиморфизма
MX2007012486A (es) Ensayos de investigacion sobre estilbazio.
ATE541924T1 (de) Selektion und isolierung lebender zellen unter verwendung rna-bindender sonden
ATE325190T1 (de) Genetische screeningverfahren
DK0750637T3 (da) CAI resistens, som koder for et protein, samt anvendelse deraf
WO2005089509A3 (en) High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
DE59814032D1 (de) Nucleinsäuremolekül, kit und verwendung
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer
ATE386140T1 (de) Methoden und reagenzien zur in situ amplifizierung
DE69837397D1 (de) Genetische veränderungen im zusammenhang mit krebs
DE69930294D1 (de) Minimale promotoren und ihre verwendung
DK0847448T3 (da) Fremgangsmåde til bestemmelse af genetisk disposition for seronegative spondylartropatier og produkter anvendelige stoffer

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: VISTAGEN, INC., SOUTH SAN FRANCISCO, CALIF., US

8364 No opposition during term of opposition